Chemed Corp
(NYSE:CHE)
$
564.785
2.735 (0.49%)
Market Cap: 8.46 Bil
Enterprise Value: 8.31 Bil
PE Ratio: 28.54
PB Ratio: 6.85
GF Score: 94/100 Chemed Corp at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022 / 10:00PM GMT
Release Date Price:
$488.62
(-0.20%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Hi, everybody. I'm A.J. Rice, healthcare service analyst at Credit Suisse. We're really pleased to have next up, once again presenting at our conference is Chemed. We have Kevin McNamara, President and CEO. We have Nick Westfall, President and CEO of the VITAS subsidiary.
Questions & Answers
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Kevin, we're 5 months or -- 5 months, I'm losing it here. We're 11 months into the year. It's been quite the year. What would you say have been some of the wins for Chemed this year? And where have been some of the challenges maybe just to level set everyone?
Kevin J. McNamara
Chemed Corporation - CEO, President & Director
Okay. Let me start then and say it's come in pretty much as guided, as expected. Roto-Rooter, another solid year on top of 2 fantastic years during the pandemic. And the comment on
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot